Get started
Boston Scientific CorporationBoston Scientific CorporationBoston Scientific Corporation

Boston Scientific Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

BSX chart


Full chart

BSX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪130.67 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
73.33
Basic EPS (TTM)
1.22 USD
Net income (FY)
‪1.59 B‬ USD
Revenue (FY)
‪14.24 B‬ USD
Shares float
‪1.47 B‬
Beta (1Y)
0.75

Employees


Employees (FY)
‪48 K‬
Change (1Y)
‪+3 K‬ +6.67%
Revenue / Employee (1Y)
‪296.67 K‬ USD
Net income / Employee (1Y)
‪33.19 K‬ USD

About Boston Scientific Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael F. Mahoney
Website
bostonscientific.com
Headquarters
Marlborough
Founded
1979
FIGI
BBG000C0LW92
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BSX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

BSX highest yielding bonds


BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049
Yield to maturity
5.87%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039
Yield to maturity
5.64%
Maturity date
Mar 1, 2039
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040
Yield to maturity
5.31%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030
Yield to maturity
5.19%
Maturity date
Jun 1, 2030
BSX.GE
Boston Scientific Corporation 6.5% 15-NOV-2035
Yield to maturity
5.07%
Maturity date
Nov 15, 2035
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025
Yield to maturity
4.87%
Maturity date
Jun 1, 2025
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029
Yield to maturity
4.82%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028
Yield to maturity
4.63%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026
Yield to maturity
4.55%
Maturity date
Mar 1, 2026
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEED
Yield to maturity
3.44%
Maturity date
Mar 8, 2034
XS245476647
A.MED.SYS.EU 22/25
Yield to maturity
3.39%
Maturity date
Mar 8, 2025

Explore more bonds 

Frequently Asked Questions


The current price of BSX is 88.95 USD — it has increased by 0.67% in the past 24 hours. Watch Boston Scientific Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Boston Scientific Corporation stocks are traded under the ticker BSX.
BSX stock has fallen by −1.42% compared to the previous week, the month change is a −1.72% fall, over the last year Boston Scientific Corporation has showed a 61.14% increase.
We've gathered analysts' opinions on Boston Scientific Corporation future price: according to them, BSX price has a max estimate of 116.00 USD and a min estimate of 86.00 USD. Watch BSX chart and read a more detailed Boston Scientific Corporation stock forecast: see what analysts think of Boston Scientific Corporation and suggest that you do with its stocks.
BSX reached its all-time high on Nov 22, 2024 with the price of 91.93 USD, and its all-time low was 2.34 USD and was reached on Oct 7, 1993. View more price dynamics on BSX chart.
See other stocks reaching their highest and lowest prices.
BSX stock is 2.77% volatile and has beta coefficient of 0.75. Track Boston Scientific Corporation stock price on the chart and check out the list of the most volatile stocks — is Boston Scientific Corporation there?
Today Boston Scientific Corporation has the market capitalization of ‪130.67 B‬, it has decreased by −0.14% over the last week.
Yes, you can track Boston Scientific Corporation financials in yearly and quarterly reports right on TradingView.
Boston Scientific Corporation is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
BSX earnings for the last quarter are 0.63 USD per share, whereas the estimation was 0.59 USD resulting in a 7.08% surprise. The estimated earnings for the next quarter are 0.66 USD per share. See more details about Boston Scientific Corporation earnings.
Boston Scientific Corporation revenue for the last quarter amounts to ‪4.21 B‬ USD, despite the estimated figure of ‪4.04 B‬ USD. In the next quarter, revenue is expected to reach ‪4.41 B‬ USD.
BSX net income for the last quarter is ‪469.00 M‬ USD, while the quarter before that showed ‪324.00 M‬ USD of net income which accounts for 44.75% change. Track more Boston Scientific Corporation financial stats to get the full picture.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has ‪48.00 K‬ employees. See our rating of the largest employees — is Boston Scientific Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Boston Scientific Corporation EBITDA is ‪3.86 B‬ USD, and current EBITDA margin is 23.71%. See more stats in Boston Scientific Corporation financial statements.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boston Scientific Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Boston Scientific Corporation technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Boston Scientific Corporation stock shows the buy signal. See more of Boston Scientific Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.